Metabolic and Bariatric Surgery Increased in Adolescents From 2021 to 2023

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 14, 2025.

By Lori Solomon HealthDay Reporter

WEDNESDAY, May 14, 2025 -- Despite the approval of second-generation antiobesity medications, metabolic and bariatric surgery (MBS) use among U.S. adolescents increased from 2021 to 2023, according to a study published online March 23 in The Journal of Pediatrics.

Sarah E. Messiah, Ph.D., M.P.H., from the University of Texas Southwestern Medical Center in Dallas, and colleagues assessed trends in adolescent MBS utilization before and after glucagon-like peptide-1 receptor agonist (GLP-1 RA) medication approval. The analysis included data from 2021, 2022, and 2023 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program participant use files.

The researchers found that adolescents had an increase in MBS completion from 2021 (1,376) to 2022 (1,490) to 2023 (1,581), while there was an increase among adults from 2021 (209,829) to 2022 (229,159) but a decrease from 2022 to 2023 (216,323). MBS completion in adolescents increased during the study period for Black and Hispanic patients, who had the highest prevalence of MBS completion versus all other racial and ethnic groups. Most adolescent completers had a preoperative body mass index (BMI) >40 kg/m2, with almost 40 percent having a BMI >50 kg/m2 across the three years. Laparoscopic sleeve gastrectomy remained the most common procedure type (>86 percent each year).

"The publication of the American Academy of Pediatrics Clinical Practice Guidelines in 2023, which endorsed MBS as a safe and effective treatment for severe obesity in adolescents, likely played a role in raising awareness and improving access," the authors write. "In addition, systemic barriers, such as limited Medicaid coverage for antiobesity medications and widespread GLP-1 RA supply shortages, may have inadvertently steered patients and providers toward MBS as a more accessible and reliable treatment option."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-15 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords